Case Studies Gilead partners with Benchling to improve large molecule bioprocess development

Edit This Case Study Record

	Gilead partners with Benchling to improve large molecule bioprocess development

Gilead partners with Benchling to improve large molecule bioprocess development

Technology Category	Platform as a Service (PaaS) - Data Management Platforms
Applicable Industries	Pharmaceuticals
Applicable Functions	Product Research & Development
Services	Cloud Planning, Design & Implementation Services
Challenge	Gilead, a global biopharmaceutical company, was facing challenges in managing data across its process development teams. The teams were using multiple systems and databases, managed through a mixture of email, Excel, and an on-premise electronic lab notebook (ELN), which resulted in data silos within and across teams. This made data capture challenging and required time-consuming manual handoffs between teams. Furthermore, aggregating data and conducting trend analysis was difficult and time-consuming, leading to less data-driven decision making. Read More
About Customer	Gilead is a global biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead’s Biologics team is focused on supporting clinical manufacturing and process development to advance the development of Gilead’s novel therapies. The company has between 10,000 and 50,000 employees and is based in Foster City, California. Read More
Solution	Gilead partnered with Benchling to improve scientist productivity, collaboration, and access to data insights. Benchling's cloud-based platform allowed for data unification, which paved the way for more efficient collaboration. The platform also enabled standardized data capture and provided an intuitive interface, which increased scientist productivity. Furthermore, Benchling made it easier for Gilead scientists to aggregate data and spot trends, enabling more data-driven decision making. Read More Log in to view content
Contents

Technology Category

Platform as a Service (PaaS) - Data Management Platforms

Applicable Industries

Pharmaceuticals

Applicable Functions

Product Research & Development

Services

Cloud Planning, Design & Implementation Services

Challenge

Gilead, a global biopharmaceutical company, was facing challenges in managing data across its process development teams. The teams were using multiple systems and databases, managed through a mixture of email, Excel, and an on-premise electronic lab notebook (ELN), which resulted in data silos within and across teams. This made data capture challenging and required time-consuming manual handoffs between teams. Furthermore, aggregating data and conducting trend analysis was difficult and time-consuming, leading to less data-driven decision making.

About Customer

Gilead is a global biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead’s Biologics team is focused on supporting clinical manufacturing and process development to advance the development of Gilead’s novel therapies. The company has between 10,000 and 50,000 employees and is based in Foster City, California.

Solution

Gilead partnered with Benchling to improve scientist productivity, collaboration, and access to data insights. Benchling's cloud-based platform allowed for data unification, which paved the way for more efficient collaboration. The platform also enabled standardized data capture and provided an intuitive interface, which increased scientist productivity. Furthermore, Benchling made it easier for Gilead scientists to aggregate data and spot trends, enabling more data-driven decision making.

Impact #1	Data unification on a centralized platform paved the way for more efficient collaboration.
Impact #2	Scientist productivity increased with standardized data capture and intuitive interface.
Impact #3	Clear insights enabled more data-driven decision making.

Impact #1

Data unification on a centralized platform paved the way for more efficient collaboration.

Impact #2

Scientist productivity increased with standardized data capture and intuitive interface.

Impact #3

Clear insights enabled more data-driven decision making.

Benefit #1	2x improvement in ease of data sharing within and across teams
Benefit #2	63% reduction in time spent on data capture, search, and collection
Benefit #3	>2x improvement in ease of study review and forecast approval

Benefit #1

2x improvement in ease of data sharing within and across teams

Benefit #2

63% reduction in time spent on data capture, search, and collection

Benefit #3

>2x improvement in ease of study review and forecast approval

Download PDF Version

Overview

Gilead partners with Benchling to improve large molecule bioprocess development

Operational Impact

Quantitative Benefit